Source:http://linkedlifedata.com/resource/pubmed/id/19054151
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0019158,
umls-concept:C0042769,
umls-concept:C0085358,
umls-concept:C0220847,
umls-concept:C0400914,
umls-concept:C0439793,
umls-concept:C0871261,
umls-concept:C1274040,
umls-concept:C1332717,
umls-concept:C1413244,
umls-concept:C1704240,
umls-concept:C1704632,
umls-concept:C1706438,
umls-concept:C1706817,
umls-concept:C2698600,
umls-concept:C2911692
|
pubmed:issue |
3
|
pubmed:dateCreated |
2009-3-5
|
pubmed:abstractText |
Aim: We investigated the relationship between the magnitude of comprehensive hepatitis C virus (HCV)-specific CD8(+) T-cell responses and the clinical course of acute HCV infection. Methods: Six consecutive patients with acute HCV infection were studied. Analysis of HCV-specific CD8(+) T-cell responses was performed using an interferon-gamma-based enzyme-linked immunospot assay using peripheral CD8(+) T-cells, monocytes and 297 20-mer synthetic peptides overlapping by 10 residues and spanning the entire HCV sequence of genotype 1b. Results: Five patients presented detectable HCV-specific CD8(+) T-cell responses against a single and different peptide, whereas 1 patient showed responses against three different peptides. Neither the magnitude of HCV-specific CD8(+) T-cell responses nor the severity of hepatitis predicts the outcome of acute hepatitis. The maximum number of HCV-specific CD8(+) T-cells correlated with maximum serum alanine aminotransferase level during the course (r = 0.841, P = 0.036). Conclusions: HCV-specific CD8(+) T-cell responses were detectable in all 6 patients with acute HCV infection, and 6 novel HCV-specific CTL epitopes were identified. Acute HCV infection can resolve with detectable HCV-specific CD8(+) T-cell responses, but without development of antibody against HCV.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:status |
PubMed-not-MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1386-6346
|
pubmed:author |
pubmed-author:BabaToshiyukiT,
pubmed-author:DoiHiroyoshiH,
pubmed-author:EguchiJunichiJ,
pubmed-author:HiraideAyakoA,
pubmed-author:HiroishiKazumasaK,
pubmed-author:ImawariMichioM,
pubmed-author:IshiiShigeakiS,
pubmed-author:ItoTakayoshiT,
pubmed-author:MatsumuraTakuyaT,
pubmed-author:MorikawaKenichiK,
pubmed-author:NozawaHisakoH,
pubmed-author:SakakiMasashiM,
pubmed-author:ShimazakiTomoeT
|
pubmed:issnType |
Print
|
pubmed:volume |
39
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
256-65
|
pubmed:year |
2009
|
pubmed:articleTitle |
Magnitude of CD8 T-cell responses against hepatitis C virus and severity of hepatitis do not necessarily determine outcomes in acute hepatitis C virus infection.
|
pubmed:affiliation |
Department of Gastroenterology, Showa University School of Medicine, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article
|